
ISPOR HEOR held a Theater focusing on discussions from the ISPOR HTA Roundtable – Middle East and Africa.
Presentations were provided by the World Health Organization, Rwanda School of Public Health, Ministry of Health of Tanzania, and Unified Procurement Authority of Egypt.
Recent Posts
EU Medicine Authorizations 2025: A Milestone for Innovation and Accessibility
EU Medicine Authorizations 2025: A Year of Innovation
Advancements in EU Medicine Authorizations for 2025
In 2025, the European Medicines Agency (EMA) recommended 104 medicines for marketing authorisati...
EU Launches Joint Scientific Consultations to Enhance Health Technology Assessment
Launching Joint Scientific Consultations in 2026
The European Commission has initiated the first submission period for Joint Scientific Consultations under the EU Health Technology Assessment (HTA) Regulation. This marks the third su...
Johnson & Johnson’s Medicine Access Agreement: Paving the Way for Cost Reduction and U...
Johnson & Johnson has reached a landmark medicine access agreement with the U.S. government, aimed at broadening access to its pharmaceutical products and slashing costs for millions of American patients. Under this voluntary arrangement during the Trump Administration, the company's medicine...